Phase 2 Readout~quarter
Phase 2 Readout: sl-325
- Company
- Shattuck Labs, Inc. (STTK)
- Drug
- sl-325
- Indication
- Crohn's disease
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.